Article metrics
Other content recommended for you
- On the random distribution of scarce doses of vaccine in response to the threat of an influenza pandemic: a response to Wardrope
- Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10
- Vaccine ethics: an ethical framework for global distribution of COVID-19 vaccines
- Scarce vaccine supplies in an influenza pandemic should not be distributed randomly: reply to McLachlan
- Socioeconomic, cultural and behavioural features of prior and anticipated influenza vaccine uptake in urban and rural Pune district, India: a mixed-methods case study
- Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations
- Safety of AS03-adjuvanted split-virion H1N1 (2009) pandemic influenza vaccine: a prospective cohort study
- Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study
- Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009
- COVID-19 vaccine barriers and perception among rural adults: a qualitative study in Bangladesh